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related to respiratory infections in infancy and to atopy. Incident
wheeze from one to 7 years was strongly associated with atopy,
while late-onset wheeze was related to rhino conjunctivitis,
smoking and (marginally) body mass.
Conclusions Advances in the understanding and prevention of
wheeze may be assisted by directing attention to maternal smoking,
breastfeeding and respiratory infections in infancy, atopy in child-
hood, rhino conjunctivitis in adolescence, and smoking and perhaps
obesity in adult life.
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Introduction and objectives The airﬂow limitation of COPD results
from small airway disease and emphysema. These phenotypes are
likely to have independent genetic risk factors. It is not known if the
heterogeneity of COPD accounts for the relatively weak association
between pack-years smoked and forced expiratory volume in 1 s
(FEV1) seen within smoking populations, or bronchodilator response
(BDR). This study aimed to assess the effect of these phenotypes on
the association between smoking and FEV1 and on BDR.
Method The international COPD genetics network is a multi-centre
study aimed at identifying genes that predispose to COPD, in which
high resolution computed tomography (HRCT) was used to quan-
tify components of the COPD phenotype: (i) emphysema detected
by radiologists (RE), (ii) emphysema assessed as per cent low-
attenuation area (%LAA) and (iii) airway wall thickness (AWT) for
airways with an internal perimeter of 10 mm (Pi10), 20 mm (Pi20),
and average per cent wall area (WA%). They were then assessed for
their effect on the association between smoking and lung function
(FEV1% predicted (FEV1%)), and on BDR.
Results RE datawere available for 1159 individuals, 745 had complete
data for Pi10, Pi20, AWT% and%LAA. The association between pack-
years smoked and FEV1% was greater in those without (r¼0.41),
compared to those with, RE (r¼0.12, p<0.001 for difference in
effect). AWT and RE correlated with FEV1% but had different rela-
tionships with smoking; AWTwas positively associated with pack-
years but therewasno relationshipbetweenRE severity andpack-years
smoked. RE, %LAA and AWT made independent contributions to
FEV1%. Post-bronchodilator increase in FEV1 was inversely associated
with severity of RE (Abstract S113 Table 1), even after adjustment for
pre-bronchodilator FEV1 (p<0.01). BDR was also inversely associated
with %LAA (p¼0.02, and p#0.05 adjusted for baseline FEV1).
Abstract S113 Table 1
Severity of RE Mild (5e25%) Moderate (25e50%) Severe (>50%) p (trend)
Number 228 185 266 e
BDR, FEV1 (mls) 171.36188.2 134.46174.7 100.26129.6 #0.0001
Conclusion The AWT component of COPD, but not the severity of
RE, increases with pack-years smoked, and the association between
pack-years and FEV1% is greatest in those with an airway
predominant phenotype. This suggests different gene-smoking
interactions between phenotypes. RE and %LAA independently
contribute to FEV1% and therefore measure different components of
emphysema, however both were inversely associated with BDR.
Measurements in patients with chronic cough
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Background Previous studies have shown a reduction in cough
response to inhaled citric acid after blocking NK1, NK2 and also
NK3 receptors in guinea pigs. NK3 receptor may be more relevant to
study the role of tachykinins in cough due to their greater speciﬁcity
for its agonist neurokinin B. We studied a speciﬁc NK3 receptor
antagonist Talnetant to determine the effect on the human cough
reﬂex sensitivity to citric acid in healthy individuals. Oral codeine
and placebo were included as comparators.
Methods Double-blind, randomised, placebo-controlled, 4-period
cross-over study in non-smoking healthy adult volunteers. A total of
28 subjects (12M, 16F) with mean age of 33 years (SD 10.5, range
22e55) were studied. Each subject received A. matched placebos; B.
Talnetant 200 mg; C.Talnetant 25 mg; D. Codeine 60 mg, in a double
blind double dummymanner. Subjectswere randomly assigned to one
of four treatment sequences (ABCD, BCDA, DCAB, BDCA). Each
study periodwas 24 hwith citric-acid challenges performed at 2, 6, 10
and 24 h post dose and a 7 day washout period between treatments.
Results There was no signiﬁcant difference in logC5 Citric acid
between Talnetant 25 mgs, 200 mgs and placebo at any time point
(see Abstract S114 Figure 1). The ‘positive’ control codeine had a
non-signiﬁcant trend for improvement in logC5 compared to
placebo (all conﬁdence intervals contained unity). Talantent was
adequately absorbed with sustained blood levels at time points
designed to coincide with the cough challenges.
Abstract S114 Figure 1
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